Haleon plc (NYSE:HLN) Receives Average Rating of “Buy” from Brokerages

Haleon plc (NYSE:HLN) has received an average rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $10.95.

A number of equities analysts have recently commented on the company. Morgan Stanley boosted their price target on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. UBS Group upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st.

Institutional Investors Weigh In On Haleon

Several hedge funds have recently modified their holdings of the company. Peapack Gladstone Financial Corp raised its position in Haleon by 3.2% in the third quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock valued at $474,000 after purchasing an additional 1,390 shares during the last quarter. Synovus Financial Corp increased its stake in shares of Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock valued at $1,575,000 after buying an additional 1,216 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in shares of Haleon in the third quarter valued at approximately $203,000. Sanctuary Advisors LLC raised its holdings in Haleon by 25.0% in the 3rd quarter. Sanctuary Advisors LLC now owns 245,310 shares of the company’s stock valued at $2,367,000 after buying an additional 49,064 shares during the last quarter. Finally, Toronto Dominion Bank boosted its position in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Down 0.1 %

Shares of HLN opened at $9.69 on Tuesday. The firm has a 50 day simple moving average of $9.71 and a two-hundred day simple moving average of $9.56. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon has a one year low of $7.89 and a one year high of $10.80. The company has a market cap of $43.86 billion, a P/E ratio of 28.50, a P/E/G ratio of 2.95 and a beta of 0.28.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.